Medication Guide - 7/29/2022

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More Drug Name Active Ingredient Form;Route Appl. No. Company Date Hyrimoz Adalimumab-Adaz INJECTABLE;INJECTION 761071 SANDOZ INC 07/18/2022 Opzelura Ruxolitinib Phosphate CREAM;TOPICAL 215309 INCYTE CORP 07/18/2022 Bavencio Avelumab INJECTABLE;INJECTION 761049 EMD SERONO INC 07/15/2022 Reyvow Lasmiditan Succinate TABLET;ORAL 211280 ELI LILLY AND CO 07/15/2022 Zonisade Zonisamide SUSPENSION;ORAL 214273 AZURITY 07/15/2022 Opdivo Nivolumab INJECTABLE;INJECTION 125554 BRISTOL MYERS SQUIBB 07/14/2022 Turalio Pexidartinib Hydrochloride CAPSULE;ORAL 211810 DAIICHI SANKYO INC 07/14/2022 Krystexxa Pegloticase INJECTABLE; INJECTION 125293 HORIZON PHARMA 07/07/2022 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA